Moderating effect of APOE ε4 on the relationship between sleep-wake cycle and brain β-amyloid

Neurology
Jeong Yeon HwangKBASE Research Group

Abstract

To clarify the relationships between sleep-wake cycle and cerebral β-amyloid (Aβ) deposition in cognitively normal (CN) older adults, focusing primarily on the moderating effects of the APOE ε4 allele. The present study included 133 CN older adults who participated in the Korean Brain Aging Study for Early Diagnosis & Prediction of Alzheimer's Disease cohort. All participants underwent [11C] Pittsburgh compound B-PET imaging to quantify Aβ deposition in the brain and blood sampling for APOE genotyping. Sleep and circadian parameters were measured using actigraphy for 8 consecutive days. The APOE ε4 allele had moderating effects on the associations of sleep latency (SL), mesor, and acrophase with cerebral Aβ deposition, and the interactions between APOE ε4 status and SL and between APOE ε4 status and acrophase remained significant after adjusting for multiple comparisons. In APOE ε4 noncarriers, shorter SL, higher mesor, and advanced acrophase were associated with Aβ positivity. In contrast, APOE ε4 carriers showed a relationship between delayed acrophase and Aβ accumulation that approached but did not reach significance. After the Bonferroni correction, the associations of shorter SL and higher mesor with Aβ positivity remained...Continue Reading

References

May 11, 1991·Lancet·P R WenhamG Blandell
May 17, 2003·Sleep·Sonia Ancoli-IsraelCharles P Pollak
Jan 31, 2004·Journal of the International Neuropsychological Society : JINS·Dong Y LeeJong I Woo
May 29, 2004·Neurobiology of Aging·David G HarperLadislav Volicer
May 12, 2005·Hormone Research·Robert J FerryLorraine E Levitt Katz
Sep 27, 2005·Neurobiology of Aging·Mirjam MünchChristian Cajochen
Sep 26, 2009·Science·Jae-Eun KangDavid M Holtzman
Dec 14, 2011·Annals of Neurology·Gregory J TranahUNKNOWN SOF Research Group
Jan 1, 2013·Biological Psychiatry·Andrew N CooganJohannes Thome
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu
Mar 13, 2013·JAMA Neurology·Yo-El S JuDavid M Holtzman
May 25, 2013·Neuroscience and Biobehavioral Reviews·Ivar ReinvangLars Tjelta Westlye
Aug 30, 2013·Journal of Intellectual & Developmental Disability·Ellen van de WouwMichael A Echteld
Oct 23, 2013·JAMA Neurology·Adam P SpiraSusan M Resnick
Dec 25, 2013·Nature Reviews. Neurology·Yo-El S JuDavid M Holtzman
Mar 4, 2015·Brain : a Journal of Neurology·Alaina Baker-NighChangiz Geula
May 20, 2015·JAMA : the Journal of the American Medical Association·Willemijn J JansenHenrik Zetterberg
Jun 2, 2015·Nature Neuroscience·Bryce A ManderMatthew P Walker
Jun 11, 2015·Neurobiology of Aging·Kate E SprecherRuth M Benca
Apr 20, 2016·Sleep·Belinda M BrownUNKNOWN AIBL Research Group
Mar 24, 2017·Alzheimer's Research & Therapy·Jong-Chan ParkInhee Mook-Jung

❮ Previous
Next ❯

Citations

Nov 19, 2019·Current Sleep Medicine Reports·Michael K Scullin, Chenlu Gao
Jul 8, 2020·International Journal of Molecular Sciences·Lyudmila KorostovtsevaEugene Shlyakhto
Sep 3, 2020·Progress in Neurobiology·Brianne A KentHaakon B Nygaard
Dec 29, 2020·Journal of Alzheimer's Disease : JAD·Maria BastaAlexandros Vgontzas
Sep 12, 2020·Sleep Medicine·S M RomanellaE Santarnecchi
Jul 1, 2021·Cardiology and Therapy·Lyudmila Korostovtseva
Aug 20, 2021·Frontiers in Aging Neuroscience·Sara López-GarcíaPascual Sánchez-Juan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

© 2022 Meta ULC. All rights reserved